【レポートの概要（一部）】
1. Executive Summary
2. Introduction to the Industry
2.1 Industry Definition
2.2 Market Profile
2.3 Market Statistics
2.4 Industry Performance
2.5 Market Segmentation
2.6 Competitive Landscape
2.7 Difference between Biotech & Pharmaceutical Industries
2.8 Biotechnology as a Business
2.9 Global Financing
2.10 Global Direct Investments
2.11 Buyer Power
2.12 Supplier Power
2.13 Market Entry
2.14 Rivalry in the Industry
2.15 Presence of Substitutes
2.16 Global Biotechnology Market: Future Perspective
3. Applications of Biotechnology
3.1 Overview
3.2 Applications in Medicine
3.3 Applications in Pharmacogenomics
3.4 Development of Pharmaceutical Products
3.5 Role of Biotechnology in Genetic Testing
3.6 Role of Biotechnology in Gene Therapy
3.7 Role of Biotechnology in Cloning
3.8 Agricultural Applications
3.9 Use of Biotechnology in Bioremediation and Biodegradation
4. Industry Segmentation
4.1 Bioinformatics
4.2 Genomics
4.3 Pharmacogenomics
4.4 Proteomics
5. Biotech Industry and Drug Development
6. Trends in the Industry
6.1 Overview
6.2 Bioinformatics
6.3 Biosensor Technology
6.4 Cell Culture Technology
6.5 Cloning Technology
6.5.1 Molecular Cloning
6.5.2 Cellular Cloning
6.5.3 Animal Cloning
6.6 DNA Chip Technology
6.7 Microarrays
6.7.1 DNA Microarrays
6.7.2 Protein Microarrays
6.7.3 Tissue Microarrays
6.7.4 Whole-Cell Microarrays
6.8 Monoclonal Antibody Technologies
6.9 Nanobiotechnology
6.10 Protein Engineering Technology
6.11 Recombinant DNA Technology
6.12 Hybrid Technology
6.13 Tissue Engineering Technology
7. Challenges Facing the Industry
7.1 Overview
7.2 Globalization of the Industry
7.3 Pressure to Improve Productivity
7.4 Energy Availability
7.5 Integrity of the Supply Chain
7.6 Decoding the Causes of Diseases
7.7 Personalized Medicine
7.8 Biosimilars/Biobetters
7.9 Right to Information
7.10 Smarter & More Cooperative Regulations
7.11 New Methods of Manufacturing
7.12 Gaining the Investor Confidence
7.13 Regulatory Barriers
7.14 Issues with Patents and Intellectual Property
7.15 Financial Issues
7.16 Challenges in Developing Countries
7.17 Issues with Genetic Manipulation
7.18 Water Issues
7.19 Issues with Commercial Product Recovery
7.20 Issues with Extensive Use of Biocatalysts
7.21 Public Outcry
8. Opportunities in Biosimilars
9. Regulation and Intellectual Property in Biotechnology
9.1 Role of Regulation
9.2 Role of Public Policy in Biotech Innovation
9.3 Role of Intellectual Property
10. Impact of the Economic Recession on the Global Biotechnology Industry
11. Biotechnology Market in Australia
11.1 Market Profile
11.2 Market Segments
11.2.1 Human Therapeutics and Diagnostics
11.2.2 Agricultural Biotechnology
11.2.3 Environmental Biotechnology
11.2.4 Food Processing
11.3 Market Size
11.4 Growth Rate
11.5 Market Drivers
11.6 Regulatory Framework
12. Biotechnology Market in Belgium
12.1 Market Statistics
12.2 Market Segmentation
12.3 Competitive Landscape
12.4 Future Perspective
13. Biotechnology Market in Brazil
13.1 Market Profile
13.2 Boom in Agricultural Biotechnology
13.3 Use of Biotechnology in the Biofuels Industry
13.4 Investment in Brazil’s Biotechnology Market
13.5 Regulatory Barriers
13.6 Future Perspective
14. Biotechnology Market in Canada
14.1 Market Statistics
14.2 Market Segmentation
14.3 Competitive Landscape
14.4 Future Perspective
15. Biotechnology Market in China
15.1 Market Profile
15.2 Market Statistics
15.3 Market Segmentation
15.4 Application Sectors of Biotechnology in China
15.4.1 Biomedicine
15.4.2 Bioagriculture
15.4.3 Industrial Biotechnology
15.4.4 Bioenergy
15.4.5 Bioenvironment
15.5 Regulations Impacting the Industry
15.6 Reforms Accelerating Growth of Biotech
15.7 Impact of the Economic Recession on China’s Biotech Industry
15.8 Public-Private Sector Interaction
15.9 Venture Capital in China’s Biotechnology Market
15.10 Role of Science Parks
15.11 Competitive Landscape
15.12 Future Perspective
16. Biotechnology Market in Cuba
17. Biotechnology Market in France
17.1 Market Statistics
17.2 Market Segmentation
17.3 Competitive Landscape
17.4 Future Perspective
18. Biotechnology Market in Germany
18.1 Market Profile
18.2 Market Statistics
18.3 Market Segmentation
18.4 Competitive Landscape
18.5 Future Perspective
19. Biotechnology Market in India
19.1 Market Profile
19.2 Segment Analysis
19.2.1 Biopharmaceuticals
19.2.2 Bioservices
19.2.3 Bioagri
19.2.4 Bioindustrial
19.2.5 Bioinformatics
19.3 Reforms Accelerating Growth of Biotech
19.4 Issue of Bt Brinjal
19.5 Growth in Stem Cell Research
19.6 Emergence of Biosimilars
19.7 Impact of the Economic Recession on India’s Biotech Industry
19.8 Investment in India’s Biotechnology Market
19.9 Industry Strategies
19.9.1 Public-Private Partnerships
19.9.2 Requirement of Higher Venture Capital Funding in India
19.9.3 Moving to a Higher Value Chain
19.9.4 Enhancing Biotech Applications
19.9.5 Lucrative Domestic Market
19.9.6 Development of Skilled Manpower
19.9.7 Shortage of Manpower
19.9.8 Relationship between Pharma and Biotech Sectors
19.9.9 Boosting North-South Collaborations
19.9.10 Requirement of Innovation in Funding Models
19.9.11 Cluster Development
19.10 Future Perspective
20. Biotechnology Market in Italy
20.1 Market Statistics
20.2 Market Segmentation
20.3 Competitive Landscape
20.4 Future Perspective
21. Biotechnology Market in Japan
21.1 Market Profile
21.2 Market Statistics
21.3 Market Segmentation
21.4 Impact of the Economic Recession on Japan’s Biotech Industry
21.5 Investment in Japan’s Biotechnology Market
21.6 Competitive Landscape
21.7 Future Perspective
22. Biotechnology Market in Malaysia
22.1 Market Profile
22.2 Healthcare Biotechnology Market
22.3 Industrial Biotechnology Market
22.4 Investment in Malaysia’s Biotechnology Market
22.5 Funding Issues
22.6 Regulatory Framework
22.7 Future Perspective
23. Biotechnology Market in the Netherlands
23.1 Market Statistics
23.2 Market Segmentation
23.3 Competitive Landscape
23.4 Future Perspective
24. Biotechnology Market in New Zealand
24.1 Market Profile
24.2 Venture Capital in New Zealand’s Biotechnology Market
24.3 Angel Investment: A Latest Trend
24.4 Investment in New Zealand’s Biotechnology Market
24.5 Reforms Accelerating Growth of Biotech
24.6 Future Perspective
25. Biotechnology Market in Pakistan
26. Biotechnology Market in Romania
27. Biotechnology Market in Singapore
27.1 Market Profile
27.2 Commercial Manufacturing in Singapore
27.3 Growth in Biotech R&D
27.4 Impact of the Economic Recession on Singapore’s Biotech Industry
27.5 Future Perspective
28. Biotechnology Market in South Korea
29. Biotechnology Market in Spain
29.1 Market Statistics
29.2 Market Segmentation
29.3 Competitive Landscape
29.4 Future Perspective
30. Biotechnology Market in Sri Lanka
31. Biotechnology Market in Switzerland
31.1 Market Profile
31.2 Growth in Number of Biotech Patents
31.3 Competitive Swiss Biotech Inventions
31.4 Venture Capital in Swiss Biotechnology Market
32. Biotechnology Market in Tanzania
33. Biotechnology Market in United Kingdom
33.1 Market Profile
33.2 Market Statistics
33.3 Market Segmentation
33.4 Competitive Landscape
33.5 Future Perspective
34. Biotechnology Market in the United States
34.1 Market Profile
34.2 Market Statistics
34.3 Market Segmentation
34.4 Competitive Landscape
34.5 Biotech Financing
34.6 Reforms in US Healthcare and Impact on Biotech Companies
34.7 Future Perspective
35. Analysis of Abbott Laboratories
35.1 Company Overview
35.2 Business Segments
35.3 Major Products & Services
35.4 SWOT Analysis
35.4.1 Strengths
35.4.2 Weaknesses
35.4.3 Opportunities
35.4.4 Threats
36. Analysis of Acorda Therapeutics
36.1 Company Overview
36.2 Business Segments
36.3 Major Products & Services
36.4 SWOT Analysis
36.4.1 Strengths
36.4.2 Weaknesses
36.4.3 Opportunities
36.4.4 Threats
37. Analysis of Actelion Ltd
37.1 Company Overview
37.2 Business Segments
37.3 Major Products & Services
37.4 SWOT Analysis
37.4.1 Strengths
37.4.2 Weaknesses
37.4.3 Opportunities
37.4.4 Threats
38. Analysis of Amgen Inc
38.1 Company Overview
38.2 Business Segments
38.3 Major Products & Services
38.4 SWOT Analysis
38.4.1 Strengths
38.4.2 Weaknesses
38.4.3 Opportunities
38.4.4 Threats
39. Analysis of Amylin Pharmaceuticals
39.1 Company Overview
39.2 Business Segments
39.3 Major Products & Services
39.4 SWOT Analysis
39.4.1 Strengths
39.4.2 Weaknesses
39.4.3 Opportunities
39.4.4 Threats
40. Analysis of Astellas Pharma
40.1 Company Overview
40.2 Business Segments
40.3 Major Products & Services
40.4 SWOT Analysis
40.4.1 Strengths
40.4.2 Weaknesses
40.4.3 Opportunities
40.4.4 Threats
41. Analysis of AstraZeneca Plc
41.1 Company Overview
41.2 Business Segments
41.3 Major Products & Services
41.4 SWOT Analysis
41.4.1 Strengths
41.4.2 Weaknesses
41.4.3 Opportunities
41.4.4 Threats
42. Analysis of Biocon Limited
42.1 Company Overview
42.2 Business Segments
42.3 Major Products & Services
43. Analysis of Biogen Idec
43.1 Company Overview
43.2 Business Segments
43.3 Major Products & Services
43.4 SWOT Analysis
43.4.1 Strengths
43.4.2 Weaknesses
43.4.3 Opportunities
43.4.4 Threats
44. Analysis of Celgene Corporation
44.1 Company Overview
44.2 Business Segments
44.3 Major Products & Services
44.4 SWOT Analysis
44.4.1 Strengths
44.4.2 Weaknesses
44.4.3 Opportunities
44.4.4 Threats
45. Analysis of Cephalon Inc
45.1 Company Overview
45.2 Business Segments
45.3 Major Products & Services
45.4 SWOT Analysis
45.4.1 Strengths
45.4.2 Weaknesses
45.4.3 Opportunities
45.4.4 Threats
46. Analysis of Crucell NV
46.1 Company Overview
46.2 Business Segments
46.3 Major Products & Services
46.4 SWOT Analysis
46.4.1 Strengths
46.4.2 Weaknesses
46.4.3 Opportunities
46.4.4 Threats
47. Analysis of CSL Limited
47.1 Company Overview
47.2 Business Segments
47.3 Major Products & Services
47.4 SWOT Analysis
47.4.1 Strengths
47.4.2 Weaknesses
47.4.3 Opportunities
47.4.4 Threats
48. Analysis of Cubist Pharmaceuticals
48.1 Company Overview
48.2 Business Segments
48.3 Major Products & Services
48.4 SWOT Analysis
48.4.1 Strengths
48.4.2 Weaknesses
48.4.3 Opportunities
48.4.4 Threats
49. Analysis of Daiichi Sankyo
49.1 Company Overview
49.2 Business Segments
49.3 Major Products & Services
49.4 SWOT Analysis
49.4.1 Strengths
49.4.2 Weaknesses
49.4.3 Opportunities
49.4.4 Threats
50. Analysis of Enzon Pharmaceuticals
50.1 Company Overview
50.2 Business Segments
50.3 Major Products & Services
50.4 SWOT Analysis
50.4.1 Strengths
50.4.2 Weaknesses
50.4.3 Opportunities
50.4.4 Threats
51. Analysis of Genzyme Corporation
51.1 Company Overview
51.2 Business Segments
51.3 Major Products & Services
51.4 SWOT Analysis
51.4.1 Strengths
51.4.2 Weaknesses
51.4.3 Opportunities
51.4.4 Threats
52. Analysis of Gilead Sciences Inc
52.1 Company Overview
52.2 Business Segments
52.3 Major Products & Services
52.4 SWOT Analysis
52.4.1 Strengths
52.4.2 Weaknesses
52.4.3 Opportunities
52.4.4 Threats
53. Analysis of Hoffmann-La Roche
53.1 Company Overview
53.2 Business Segments
53.3 Major Products & Services
53.4 SWOT Analysis
53.4.1 Strengths
53.4.2 Weaknesses
53.4.3 Opportunities
53.4.4 Threats
54. Analysis of ImmunoGen, Inc
54.1 Company Overview
54.2 Business Segments
54.3 Major Products & Services
54.4 SWOT Analysis
54.4.1 Strengths
54.4.2 Weaknesses
54.4.3 Opportunities
54.4.4 Threats
55. Analysis of LifeCell Corporation
55.1 Company Overview
55.2 Business Segments
55.3 Major Products & Services
56. Analysis of Mitsubishi Tanabe Pharma Corporation
56.1 Company Overview
56.2 Business Segments
56.3 Major Products & Services
56.4 SWOT Analysis
56.4.1 Strengths
56.4.2 Weaknesses
56.4.3 Opportunities
56.4.4 Threats
57. Analysis of OSI Pharmaceuticals
57.1 Company Overview
57.2 Business Segments
57.3 Major Products & Services
57.4 SWOT Analysis
57.4.1 Strengths
57.4.2 Weaknesses
57.4.3 Opportunities
57.4.4 Threats
58. Analysis of Takara Holdings
58.1 Company Overview
58.2 Business Segments
58.3 Major Products & Services
58.4 SWOT Analysis
58.4.1 Strengths
58.4.2 Weaknesses
58.4.3 Opportunities
58.4.4 Threats
59. Analysis of UCB SA
59.1 Company Overview
59.2 Business Segments
59.3 Major Products & Services
59.4 SWOT Analysis
59.4.1 Strengths
59.4.2 Weaknesses
59.4.3 Opportunities
59.4.4 Threats
60. Analysis of Vertex Pharmaceuticals
60.1 Company Overview
60.2 Business Segments
60.3 Major Products & Services
60.4 SWOT Analysis
60.4.1 Strengths
60.4.2 Weaknesses
60.4.3 Opportunities
60.4.4 Threats
61. Analysis of ViroPharma Incorporated
61.1 Company Overview
61.2 Business Segments
61.3 Major Products & Services
61.4 SWOT Analysis
61.4.1 Strengths
61.4.2 Weaknesses
61.4.3 Opportunities
61.4.4 Threats
62. Analysis of ZymoGenetics Inc
62.1 Company Overview
62.2 Business Segments
62.3 Major Products & Services
62.4 SWOT Analysis
62.4.1 Strengths
62.4.2 Weaknesses
62.4.3 Opportunities
62.4.4 Threats
63. Appendix
64. Glossary
【レポート販売概要】
■ タイトル：世界のバイオ技術市場■ 英文：Global Biotechnology Market
■ 発行日：2013年12月
■ 調査会社：Taiyou Research
■ 商品コード：TAYU40206058
■ 調査対象地域：世界
- BRIC（ブラジル・ロシア・インド・中国）の睡眠時無呼吸診断装置市場BRIC Sleep Apnea Diagnostic Systems Market Outlook to 2021 Summary GlobalData’s new report, "BRIC Sleep Apnea Diagnostic Systems Market Outlook to 2021", provides key market data on the BRIC Sleep Apnea Diagnostic Systems market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments Fixed Polysomnography Systems and P …
- 食道無弛緩症(Esophageal Achalasia)：世界の治験レビュー（2015年上半期版）Esophageal Achalasia Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Esophageal Achalasia Global Clinical Trials Review, H1, 2015" provides data on the Esophageal Achalasia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Esophageal Achalasia. It includes an overview of the trial numbers and their r …
- 医療用ロボットの世界市場：手術ロボット、リハビリロボット、病院ロボット、補助ロボット、遠隔医療ロボットMedical robots, an emerging field in healthcare is causing a paradigm shift in healthcare as it improves the quality of patient care. Demographic change, shortage of healthcare professionals, need to improve quality of life for the disabled and elderly, and need to improve surgical procedures coupled with the focus to develop technologically advanced robots are some of the factors expected to stim …
- エポキシ化大豆油（ESBO）の世界市場ESBO is majorly used as a plasticizer and stabilizer for PVC compounds and gradually evolved its reach to other application segments. The demand for ESBO is high as it has excellent compatibility and thermal stability. ESBO is being used as the preferred substitute for phthalate plasticizers by major PVC manufacturers and suppliers globally. The North America region is the largest consumer of ESBO …
- Transportadora de Gas del Sur S.A.：石油・ガスバリューチェーン分析レポート2013Transportadora de Gas del Sur S.A. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Transportadora de Gas del Sur S.A." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Transportadora de Gas del Sur S.A.”. The report provides key information relating to oil and gas assets of the company along with its operatio …
- NFV（ネットワーク機能の仮想化）の世界市場：ビジネス事例、市場分析、予測Network Functions Virtualization (NFV) is a telecom led initiative that aims to utilize standard IT virtualization technology to consolidate many telecom network equipment types onto industry standard high volume servers, switches and storage. NFV involves implementing network functions in software that can run on a range of industry standard server hardware, and that can be moved to, or instantia …
- 生物製剤の世界市場動向・予測2016-2026Biological Drugs – Discover Revenue Potentials Now, Benefiting Your Authority Do you want to find how high biological drug sales can go? Visiongain’s new analysis gives you those revenue forecasts to 2026 at overall world market, therapeutic class and national level. For biologics you discover data, opportunities, R&D and sales potentials. Our updated report gives you multilevel revenue prediction …
- 患者モニタリング機器/システム/装置の世界市場予測（～2023年）“The patient monitoring devices market is projected to grow at a CAGR of 5.7% during the forecast period.”The patient monitoring devices market is expected to reach USD 25.31 billion by 2023 from USD 19.14 billion in 2018, at a CAGR of 5.7%. The scope of the report includes patient monitoring devices used for the continuous monitoring, detection, and treatment of heart, blood, brain, lungs activit …
- 世界のコラーゲンペプチド市場2015The Global Collagen Peptides Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Collagen Peptides industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Collagen Peptides market analysis is provided for the international markets including development tren …
- 屋根材用接着剤世界市場2017-2021ABSTRACTAbout Roofing Adhesive Roofing is the process of covering the uppermost surface and supporting structures of a building with materials such as shingles, membranes, insulating glass, and cement. There are two main types of roofing defined by the pitch or slope of the roof: steep-slope roofing and low-sloped or flat roofing. Roofing adhesives are substances used to bind the roof surfaces, th …
- Anorexia Nervosa：グローバル臨床試験レビューH1, 2013Anorexia Nervosa Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Anorexia Nervosa Global Clinical Trials Review, H1, 2013" provides data on the Anorexia Nervosa clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Anorexia Nervosa. It includes an overview of the trial numbers and their recruitment statu …
- 世界のインスリン投与デバイス市場動向（～2019）Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers Summary GBI Research’s report, 'Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers' looks at the market, competitive landscape, and trends for the four insulin delivery devices market segments: …
- ヘビーデューティ型ポンプの世界市場ABSTRACTAbout Heavy Duty Pumps Heavy-duty pumps are mechanical devices that are used to transport fluids. These pumps have major applications in industries such as construction, mining, oil and gas, wastewater, pulp, pharmaceutical, and food and beverage. The major end-users of the market include oil and gas, processing, and other industries. The rise in investment in pumps by these end-user segme …
- 熱帯性痙性不全対麻痺症：治療薬の治験動向（2014年下半期）Tropical Spastic Paraparesis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Tropical Spastic Paraparesis Global Clinical Trials Review, H2, 2014" provides data on the Tropical Spastic Paraparesis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tropical Spastic Paraparesis. It includes an overview …
- 分子量マーカーの世界市場分析、製品別（DNA、タンパク質、RNAマーカー）、用途別（PCR、シークエンシング、ノーザンブロッティング、サザンブロッティング、分子クローニング、ウェスタンブロッティング、ゲル抽出）、タイプ別、セグメント予測、2014-2025The global molecular weight marker market is expected to reach a value of USD 1.1 billion by 2025, according to a new report by Grand View Research, Inc. Increasing investment in R&D by companies including biotechnology and biologics is the major factor that drives the growth during the forecast period. These markers are used by researchers and companies for various applications such as polymerase …
